To decrease violence or accidents, Drug for Abuse Testing Devices on the roads are being popular which is expected to boost Drug for Abuse Testing Devices Market growth

 

Drug for Abuse Testing Devices Market is Segmented by Product Type (Analyzers (Immunoassay Analyzers, Chromatographic Devices, and Breath Analyzers), Rapid Testing Devices (Urine Testing Devices and Oral Fluid Testing Devices), and Consumables), Sample Type (Saliva, Urine, Blood, and Other Sample Types), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, and Other End Users), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Drug for Abuse Testing Devices Market is estimated to be valued at US$ 2332.84 million in 2021, and is expected to exhibit a CAGR of 3.9 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The drug of abuse test is an immunoassay test on the working of competitive binding. Medicines that may be involved in the urine samples contend against their particular drug conjugate for binding sites on their particular antigen. Through testing, a part of the urine sample drifts upward by duct action.

Competitive Landscape:

Key players involved in the global Drug for Abuse Testing Devices Market are Hoffmann-La Roche Ltd, LabCorp, Quest Diagnostics Inc., Danaher Corporation, Siemens Healthineers AG, Abbott Laboratories., Drägerwerk AG & Co. KGaA, F., and Thermo Fisher Scientific Inc.

Market Key Drivers:

To decrease violence or accidents, Drug for Abuse Testing Devices on the roads are being popular which is expected to boost the growth of global Drug for Abuse Testing Devices Market. For instance, as per the data published by OECD in 2020, around one in three adults in the EU over 97 million people have consumed illicit drugs at least once in life.

Increasing technological developments, guidelines by the suppliers, and increasing fatalities owing to rising consumption of drug overdose is projected to propel the growth of global Drug for Abuse Testing Devices Market. For instance, in April 2020, WellCare Health Plans declared the new medical coverage rules and assures payment policy for urine drug trial and involves definitive urine drug trial as clinically essential as part of a routine screening program for people who attain therapy for chronic pain with suggested opioid.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of the global Drug for Abuse Testing Devices Market due to the surge in pandemic cases. The rising pandemic cases has shifted the focus of physicians towards curing Covid-19 patients. The delay in treating other disorders is anticipated to impede market growth.

Key Takeaways:

The global Drug for Abuse Testing Devices Market is anticipated to exhibit a CAGR of 3.9 % during the forecast period owing to the rising approvals and product launches. For instance, In June 2022, Punjab Government (India) introduced a drug screening program in jails to identify drug abuse in jails. The test of around 8,000 prisoners in almost 14 jails has detected that 42% of prisoners were addicted to drugs.

 

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global Drug for Abuse Testing Devices Market due to increasing mergers and acquisitions, increasing partnerships and collaborations and rising addiction drugs. For instance, in October 2022, the CDC introduced four education campaigns focusing at inhibiting deaths related to drug overdose.